Press release title: ‘Cancer cases increasing in under 50s in England, with prostate cancer showing steepest rise, says charity’, from the World Cancer Research Fund International. There is no full ...

“Pneumonic plague is particularly serious because it means the infection has reached the lungs and is nearly always fatal if not treated promptly. Unlike the bubonic plague which enters the body via ...

“The Series therefore provides a useful framework for considering digital technologies as a public health issue, while also highlighting the urgent need for greater access to platform data (controlled ...

‘Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study’ by Saraid McIlvride et al. was published in PLOS Medicine at 19:00 UK time on ...

‘Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial’ by W Timothy Garvey et al. was published in The Lancet ...

Scientists comment on a study examining incidence of type 1 diabetes in children receiving rotavirus vaccine; secondary analysis suggests vaccine not cause of observed 11% relative increase, as ...

September 28, 2026 expert reaction to umbrella review of studies looking at screen use and child and adolescent development . Scientists comment on an umbrella review of studies l ...

‘GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis’ by Francesco D’Antonio et al. was published in Med at 16:00 UK ...

Scientist comment on a study, published in Diabetes, on UPF consumption, physical activity, genetic susceptibility and type 2 diabetes, which is being presented at the European Association for the ...

Scientist comment on a systemic review and meta-analysis, published in The Lancet Obstetrics, Gynaecology & Women’s Health, looking at preconception, pregnancy, and postnatal use of GLP-1 RAs in women ...

October 1, 2026 expert reaction to conference abstract about a phase 2 trial of a new weight loss injection, CBL-514, and levels of subcutaneous and visceral fat, presented at the ...